Dapiprazole
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a601043 |
Pregnancy category |
|
Routes of administration | Topical (eye drops) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Negligible when administered topically |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H27N5 |
Molar mass | 325.460 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.[1]
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- Articles with changed EBI identifier
- Drugboxes which contain changes to verified fields
- Alpha-1 blockers
- Phenylpiperazines
- Triazolopyridines
- Ophthalmology drugs
- 2-Tolyl compounds
- All stub articles
- Antihypertensive agent stubs